UniSuper Management’s CONMED CNMD Stock Holding History

UniSuper Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,401	Closed	-$582K	–	764
2024 Q2	$582K	Hold	8,401	–	–	﹤0.01%	732
2024 Q1	$673K	Buy	+8,401	New	+$749K	0.01%	662

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

UniSuper Management's CNMD Position: Q3 2024 in Review

UniSuper Management sold out of CONMED (CNMD) in Q3 2024, closing a stake of 8,401 shares — an estimated $582K sold.

UniSuper Management first reported a position in CNMD in Q1 2024 and held it in 2 quarters. The position peaked at $673K in Q1 2024. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

UniSuper Management reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
UniSuper Management sold 8,401 CONMED shares in Q3 2024, an estimated $582K.
UniSuper Management first reported a position in CONMED in Q1 2024 and held it in 2 quarters.
UniSuper Management's CONMED position peaked at $673K in Q1 2024.
290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on UniSuper Management's 13F filing for Q3 2024, filed 14 Nov 2024.